lenacapavir Archives -

The FDA has given ViiV healthcare and Johnson & Johnson a boost in the market for long-acting injectable

ViiV, J&J get FDA nod for simpler HIV injectable dosing

https://pharmaphorum.com/news/viiv-jj-get-fda-nod-for-simpler-hiv-injectable-dosing/

Gilead Sciences has filed for FDA approval of a long-acting therapy for resistant HIV infections that only needs

Gilead challenges ViiV in resistant HIV, filing twice-yearly therapy

https://pharmaphorum.com/news/gilead-challenges-viiv-in-resistant-hiv-filing-twice-yearly-therapy/

Gilead Sciences has the data it was hoping for in a pivotal trial of lenacapavir, an HIV drug

Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir

https://pharmaphorum.com/news/data-sets-up-2021-filings-for-gileads-twice-a-year-hiv-drug-lenacapavir/

lenacapavir